BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28637198)

  • 21. Structural basis of the allosteric inhibitor interaction on the HIV-1 reverse transcriptase RNase H domain.
    Christen MT; Menon L; Myshakina NS; Ahn J; Parniak MA; Ishima R
    Chem Biol Drug Des; 2012 Nov; 80(5):706-16. PubMed ID: 22846652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug targeting of HIV-1 RNA.DNA hybrid structures: thermodynamics of recognition and impact on reverse transcriptase-mediated ribonuclease H activity and viral replication.
    Li TK; Barbieri CM; Lin HC; Rabson AB; Yang G; Fan Y; Gaffney BL; Jones RA; Pilch DS
    Biochemistry; 2004 Aug; 43(30):9732-42. PubMed ID: 15274628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The nature of the N-terminal amino acid residue of HIV-1 RNase H is critical for the stability of reverse transcriptase in viral particles.
    Boso G; Örvell C; Somia NV
    J Virol; 2015 Jan; 89(2):1286-97. PubMed ID: 25392207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is affected by the thumb subdomain of the small protein subunits.
    Sevilya Z; Loya S; Hughes SH; Hizi A
    J Mol Biol; 2001 Aug; 311(5):957-71. PubMed ID: 11531332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 6-[1-(4-Fluorophenyl)methyl-1H-pyrrol-2-yl)]-2,4-dioxo-5-hexenoic acid ethyl ester a novel diketo acid derivative which selectively inhibits the HIV-1 viral replication in cell culture and the ribonuclease H activity in vitro.
    Tramontano E; Esposito F; Badas R; Di Santo R; Costi R; La Colla P
    Antiviral Res; 2005 Feb; 65(2):117-24. PubMed ID: 15708638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of an Mg2+-dependent HIV-1 RNase H construct for drug screening.
    Farias RV; Vargas DA; Castillo AE; Valenzuela B; Coté ML; Roth MJ; Leon O
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4735-41. PubMed ID: 21768506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alizarine derivatives as new dual inhibitors of the HIV-1 reverse transcriptase-associated DNA polymerase and RNase H activities effective also on the RNase H activity of non-nucleoside resistant reverse transcriptases.
    Esposito F; Kharlamova T; Distinto S; Zinzula L; Cheng YC; Dutschman G; Floris G; Markt P; Corona A; Tramontano E
    FEBS J; 2011 May; 278(9):1444-57. PubMed ID: 21348941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-1 integrase and RNase H activities as therapeutic targets.
    Andréola ML; De Soultrait VR; Fournier M; Parissi V; Desjobert C; Litvak S
    Expert Opin Ther Targets; 2002 Aug; 6(4):433-46. PubMed ID: 12223059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutational analysis of Tyr-501 of HIV-1 reverse transcriptase. Effects on ribonuclease H activity and inhibition of this activity by N-acylhydrazones.
    Arion D; Sluis-Cremer N; Min KL; Abram ME; Fletcher RS; Parniak MA
    J Biol Chem; 2002 Jan; 277(2):1370-4. PubMed ID: 11684697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2-(Arylamino)-6-(trifluoromethyl)nicotinic Acid Derivatives: New HIV-1 RT Dual Inhibitors Active on Viral Replication.
    Corona A; Onnis V; Del Vecchio C; Esposito F; Cheng YC; Tramontano E
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32183488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flavonoids and Acid-Hydrolysis derivatives of
    Fois B; Corona A; Tramontano E; Distinto S; Maccioni E; Meleddu R; Caboni P; Floris C; Cottiglia F
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):749-757. PubMed ID: 33715562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones.
    Budihas SR; Gorshkova I; Gaidamakov S; Wamiru A; Bona MK; Parniak MA; Crouch RJ; McMahon JB; Beutler JA; Le Grice SF
    Nucleic Acids Res; 2005; 33(4):1249-56. PubMed ID: 15741178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-1 RNase H: recent progress in an exciting, yet little explored, drug target.
    Tramontano E
    Mini Rev Med Chem; 2006 Jun; 6(6):727-37. PubMed ID: 16787384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural and binding analysis of pyrimidinol carboxylic acid and N-hydroxy quinazolinedione HIV-1 RNase H inhibitors.
    Lansdon EB; Liu Q; Leavitt SA; Balakrishnan M; Perry JK; Lancaster-Moyer C; Kutty N; Liu X; Squires NH; Watkins WJ; Kirschberg TA
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2905-15. PubMed ID: 21464257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of HIV-1 ribonuclease H by a novel diketo acid, 4-[5-(benzoylamino)thien-2-yl]-2,4-dioxobutanoic acid.
    Shaw-Reid CA; Munshi V; Graham P; Wolfe A; Witmer M; Danzeisen R; Olsen DB; Carroll SS; Embrey M; Wai JS; Miller MD; Cole JL; Hazuda DJ
    J Biol Chem; 2003 Jan; 278(5):2777-80. PubMed ID: 12480948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro anti-angiogenic effects of Hemidesmus indicus in hypoxic and normoxic conditions.
    Turrini E; Ferruzzi L; Guerrini A; Gotti R; Tacchini M; Teti G; Falconi M; Hrelia P; Fimognari C
    J Ethnopharmacol; 2015 Mar; 162():261-9. PubMed ID: 25560668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combinatorial selection, inhibition, and antiviral activity of DNA thioaptamers targeting the RNase H domain of HIV-1 reverse transcriptase.
    Somasunderam A; Ferguson MR; Rojo DR; Thiviyanathan V; Li X; O'Brien WA; Gorenstein DG
    Biochemistry; 2005 Aug; 44(30):10388-95. PubMed ID: 16042416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory effects of Korean plants on HIV-1 activities.
    Min BS; Kim YH; Tomiyama M; Nakamura N; Miyashiro H; Otake T; Hattori M
    Phytother Res; 2001 Sep; 15(6):481-6. PubMed ID: 11536375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, and biological evaluation of 1,3-diarylpropenones as dual inhibitors of HIV-1 reverse transcriptase.
    Meleddu R; Cannas V; Distinto S; Sarais G; Del Vecchio C; Esposito F; Bianco G; Corona A; Cottiglia F; Alcaro S; Parolin C; Artese A; Scalise D; Fresta M; Arridu A; Ortuso F; Maccioni E; Tramontano E
    ChemMedChem; 2014 Aug; 9(8):1869-79. PubMed ID: 24850787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selection of mutations in the connection and RNase H domains of human immunodeficiency virus type 1 reverse transcriptase that increase resistance to 3'-azido-3'-dideoxythymidine.
    Brehm JH; Koontz D; Meteer JD; Pathak V; Sluis-Cremer N; Mellors JW
    J Virol; 2007 Aug; 81(15):7852-9. PubMed ID: 17507476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.